Thank you for reading the news about Coronavirus: Life back to normal by spring? UK expert says 'Yes, yes, yes' and now with the details
Aden - Yasmine El Tohamy - Professor John Bell hails Pfizer's experimental vaccine and says no reason 'why we shouldn't have a handful of good vaccines available to this disease'.
One of the teams racing to develop a coronavirus vaccine announced Monday its drug had shown 90 per cent effectiveness against the illness, sending stock markets soaring and raising hopes of an end to draconian restrictions on movement.
US pharmaceutical giant Pfizer said tests involving more than 40,000 people had provided results that were a "critical milestone" in the search for a vaccine, as global infections soared passed 50 million -- almost one-fifth of them in the United States.
John Bell, regius professor of medicine at University of Oxford who sits on the British government's vaccine taskforce, told BBC Radio he could not see "any reason now why we shouldn't have a handful of good vaccines available to this disease".
He added that he was "optimistic that given this result, we'll have a reasonably good chance of getting a good result as well," referring to Oxford's own late-stage trial results he said would come in "weeks not months".
Asked if life would be returning to normal by the spring, Oxford's Bell said: "Yes, yes, yes."
"I'm probably the first guy to say that but...I will say that with some confidence."
These were the details of the news Coronavirus: Life back to normal by spring? UK expert says 'Yes, yes, yes' for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Khaleej Times and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
